Medtech stories we missed this week: June 15, 2018

From Cytosorbents opening a new U.S. manufacturing facility to DyAnsys received FDA clearance for a wearable to treat opioid withdrawals, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Cytosorbents opens new U.S. manufacturing facility CytoSorbents announced in a June 12 press release that it has opened a new

DARPA is developing nonsurgical neural interfaces to expand neurotechnology

Researchers from the Defense Advanced Research Projects Agency (DARPA) have recently started a new program called Next-Generation Nonsurgical Neurotechnology to develop a non-invasive brain-system communications system to allow patients to communicate with devices using their brain. State-of-the-art brain communications systems that exist today are traditionally invasive, but allow for precise, high-quality connections to specific neurons

10 women medtech leaders you should know

There is a women’s leadership gap in the U.S., and women in medtech have been working to alleviate that problem. According to a report from the Centers for American Progress, women hold 52% of professional jobs in the U.S., but only 14.6% are CEOs, 8.1% are top earners and 4.6% are Fortune 500 CEOs. More specifically,

Pages: 1 2 3 4 5 6 7 8 9 10 11

8 women medtech innovators you need to know

As we celebrate more women becoming medtech leaders and paving the way for innovation, it’s important to remember the many accomplishments women have already made when it comes to the advancement of health and medicine. X-rays on the battlefield, the American Red Cross, leprosy treatment and more — these advances happened because of women. As

Pages: 1 2 3 4 5 6 7 8 9

How noninvasive brainwave technology improved PTSD in veterans

A noninvasive brainwave mirroring technology recently showed potential in reducing symptoms of post-traumatic stress disorder in military personnel, according to a study from Wake Forest Baptist Medical Center. The U.S. Department of Veterans Affairs reports that PTSD affects about 11-20% of Operations Iraqi Freedom and and Enduring Freedom veterans, 12% of Gulf War veterans and

7 medical devices combating the opioid crisis

Opioid-related deaths have become an epidemic in the U.S., garnering attention from the White House, the FDA and many other governmental bodies. From 2000 to 2014, nearly half a million Americans died from drug overdoses. In 2015, more than 50,000 people died from drug overdoses, and 33,000 were opioid-related. Prescription overdoses continue to cause more

Pages: 1 2 3 4 5 6 7 8

Medtech stories we missed this week: Nov. 17, 2017

From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics.

How a versatile epoxy is enabling brain stimulation

In but another example of how useful and critical epoxies can be, researchers in Israel used a two-part epoxy to construct a magnetic coil to stimulate animal brain neurons via a magnetic field. Rohit Ramnath, Master Bond Designers of medical electronics assemblies have many options to choose from when selecting one or more compounds for

Medtech stories we missed this week: July 21, 2017

From Second Sight’s South Korean market entry to Sanuwave’s Indonesian distribution deal, here are medtech stories we missed this week but thought were still worth mentioning. 1. Second Sight enters South Korea market Second Sight announced in a July 5 press release that it has entered the market in South Korea with the implantation of two

Medtech stories we missed this week: July 14, 2017

From Novarad touting its VR-surgical guidance system to Zynex paying off its $2.2M loan, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Stimwave announces first patient in Brazil Stimwave announced in a July 5 press release that its first patients in Brazil have received Stimwave’s wireless pain relief

Philips is bringing augmented reality to surgery: Here’s how

Royal Philips, a leader in integrated image-guided therapy solutions, has developed an augmented-reality (AR) surgical navigation technology. The new technology is designed to help surgeons perform image-guided open and minimally-invasive spine surgery. Philips has 750 hybrid operating rooms installed worldwide to assist with surgical and minimally-invasive endovascular procedures. These hybrid OR solutions paired with the

Nonin Medical launches next generation LifeSense II and RespSense II Capnographs

Nonin Medical, the inventor of finger pulse oximetry and a developer in noninvasive medical monitoring, announced it has launched the next generation of end-tidal CO2 monitors in the LifeSense II capnograph/pulse oximeter and RespSense II capnograph. The Nonin LifeSense II and RespSense II are value-priced monitors that are ideal for a wide range of medical monitoring

CNOGA Medical appointed ARTECH to distribute their non-­invasive medical devices in Italy

CNOGA Medical, a developer and manufacturer of non-­invasive medical monitoring device, is pleased to announce that they have signed a distribution agreement with ARTECH S.R.L. CAVEZZO MO, Italy to distribute CNOGA’s Tensor TipTM Non­invasive devices in Italy. The MTX non­invasive device, from CNOGA’s Tensor TipTM Family, is capable of monitoring 14 parameters, such as blood

PathMaker Neurosystems announces key patent issuance by U.S. Patent and Trademark Office for fundamental technology covering MyoRegulator

PathMaker Neurosystems, a clinical-stage neurotechnology company developing non-invasive neurotherapy systems for the treatment of patients with neuromotor disorders, announced that the U.S. Patent and Trademark Office has granted a fundamental patent (U.S. Patent 9,283,391) covering its proprietary DoubleStim technology that forms the basis of our MyoRegulator system, a first-in-class non-invasive device now in human clinical trials

Spineology introduces new Palisade Pedicular Fixation System at AANS

Spineology, an innovator in anatomy-conserving surgery, announces the full U.S. market release of its Palisade Pedicular Fixation System. The Palisade Pedicular Fixation System is designed to minimize surgical invasiveness and enhance efficiency. The integrated break-off screw extensions and quick-start screw design minimize procedural steps and limit tissue disruption during screw insertion and rod placement. “Palisade is the